Newsletter

Next-Generation Dyslipidemia Drugs Show Significant Reduction in Lipid Levels at ACC.24 Conference

#74% reduction in triglyceride levels (floxasiran)#Reduce neutral fat levels by half (olesarsen)#Reduction of LDL cholesterol level by more than half (Rerodalcibef) During the American College of Cardiology’s annual scientific session (ACC.24), new drug candidates considered the next generation of dyslipidemia were revealed. In patients with severely elevated triglyceride levels, flozasiran reduced triglyceride levels by an […]

Long-Term Follow-Up Results of PSA Testing for Prostate Cancer: Controversy Persists

While controversy continues over the effectiveness of the prostate-specific antigen (PSA) test for detecting prostate cancer, long-term follow-up results over 15 years have been only half successful. Although a decrease in mortality was observed in PSA testers, there was little difference in the absolute number of deaths, so controversy over its effectiveness is expected to […]

Study Finds Varying Risk of Birth Defects in Infants Exposed to Different Anticonvulsants During Pregnancy

Research findings have shown that the risk of serious birth defects varies depending on the ingredients of anticonvulsants taken by pregnant women with epilepsy. Infants exposed to levetiracetam, oxcarbazepine, and lamotrigine had a relatively low risk of malformations, but those exposed to carbamazepine, phenobarbital, and valproate had a higher risk, with levetiracetam (2.5%) and valproate […]

Hanmi Pharmaceutical to Unveil 10 New Research Projects at AACR 2024

Hanmi Science (hereinafter referred to as Hanmi Group), a core business company, Hanmi Pharmaceutical, will participate in the ‘American Association for Cancer Research (AACR 2024)’ held in San Diego, USA from April 5 to 10 and reveals 10 new research projects, the largest number in the industry It was announced on the 18th that it […]

Hanmi Pharmaceutical Set to Unveil 10 New Research Projects at AACR 2024

Hanmi Science (hereinafter referred to as Hanmi Group), a core business company, Hanmi Pharmaceutical, will participate in the ‘American Association for Cancer Research (AACR 2024)’ held in San Diego, USA from April 5 to 10 and reveals 10 new research projects, the largest number in the industry It was announced on the 18th that it […]

Study Finds Light Therapy Ineffective for Adolescent Depression

One study found that light therapy was not effective for adolescents with major depressive disorder. Research results have shown that the effect of light therapy on adolescent depression is not significant. The results of a phototherapy study in adolescents with moderate to severe depression led by researchers including Tanja Legenbauer of Ruhr University in Bochum, […]

Metformin Confirmed to have Kidney-Protective Effect in Patients with Type 2 Diabetes

The research findings confirmed the kidney-protective effect of metformin, a first-line treatment for diabetes. There are conflicting opinions about metformin’s protective effect on the kidneys, but new research shows that it not only prevents diabetic nephropathy, but also reduces the risk of serious renal and cardiovascular events regardless of kidney function status. The results of […]